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Abstract
Background: The long-term effect of hip fracture on health-related quality of life (HRQOL) and global quality of life
(GQOL) has not been thoroughly studied in prospective case-control studies.
Aims: a) to explore whether patients with low-energy hip fracture regain their pre-fracture levels in HRQOL and
GQOL compared with changes in age- and sex-matched controls over a two year period; b) to identify predictors
of changes in HRQOL and GQOL after two years.
Methods: We examined 61 patients (mean age = 74 years, SD = 10) and 61 matched controls (mean age = 73
years, SD = 8). The Short Form 36 assessed HRQOL and the Quality of Life Scale assessed GQOL. Paired samples t
tests and multiple linear regression analyses were applied.
Results: HRQOL decreased significantly between baseline and one-year follow-up in patients with hip fractures,
within all the SF-36 domains (p < 0.04), except for social functioning (p = 0.091). There were no significant
decreases within the SF-36 domains in the controls. Significantly decreased GQOL scores (p < 0.001) were observed
both within patients and within controls between baseline and one-year follow-up. The same pattern persisted
between baseline and two-year follow-up, except for the HRQOL domain mental health (p = 0.193). The patients
with hip fractures did not regain their HRQOL and GQOL. Worsened physical health after two years was predicted
by being a patient with hip fracture (B = -5.8, p < 0.001) and old age (B = -1.0, p = 0.015), while worsened mental
health was predicted by co-morbidity (B = -2.2, p = 0.029). No significant predictors of differential changes in
GQOL were identified.
Conclusion: A hip fracture has a long-term impact on HRQOL and is a strong predictor of worsened physical
health. Our data emphasize the importance of preventing hip fracture in the elderly to maintain physical health.
This knowledge should be included in decision-making and health care plans.
Background
With age, the incidence of hip fractures in the elderly
increases exponentially due to increased prevalence of
osteoporosis and increased risk of falls [1-4]. In the
e l d e r l y ,t h em a j o r i t yo fh i pf r a c t u r e sa r ear e s u l to fa
low-energy trauma [4,5], defined as falls from standing
height or less [6]. Fracture at the hip may imply pain
and reduced physical functioning months and years
after the fracture [7-9], and may consequently affect
quality of life (QOL).
QOL is considered a subjective phenomenon, which is
often assessed through self-report and thereby supple-
ments objective factors associated with disease, in this
context hip fracture and bone mineral density (BMD).
Traditionally, QOL comprises both health-related qual-
ity of life (HRQOL) and global quality of life (GQOL)
[10]. HRQOL may be defined as the individual’s experi-
ence of their general state of health, such as physical,
social, and mental well-being [11], and GQOL may be
defined as a broad range of human experiences related
to one’s overall well-being and satisfaction, and has a
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QOL perspective includes both the health aspect
(HRQOL) and satisfaction with life as a whole (GQOL).
Previous QOL studies in patients with hip fracture
have shown that HRQOL decreases after a hip fracture,
and that physical health is influenced more by the frac-
ture than mental health [8,9,15-18]. Furthermore,
HRQOL seems to decrease more after a hip fracture in
patients who had low HRQOL before the fracture than
in those with higher scores [18]. Additionally, studies
focusing on predictors of changes in HRQOL after a hip
fracture show that low body mass index (BMI) and low
BMD are associated with reduced HRQOL two years
after a low-energy hip fracture in postmenopausal
women [7].
To the best of our knowledge, no studies have
assessed whether patients with hip fractures regain their
pre-fracture GQOL after the fracture, nor have predic-
tors of changes in GQOL in patients with low-energy
hip fracture been identified. Furthermore, the complex-
ity of the consequences of hip fractures, including both
an objective perspective (e.g., BMD, BMI, demographic,
and clinical indicators) and a subjective perspective (e.g.,
QOL) on changes, needs to be addressed. Knowledge
about these issues may provide patients, providers, and
decision makers with important information on the
impact of disease and treatment on physical, psychologi-
cal, social functioning, and well-being, and satisfaction
with life. Thus, the patient’s subjective perspective may
be included in decision making and health care plans,
such as contact and collaboration of health care between
the hospitals and the health care units in the municipali-
ties after the fracture [19,20].
Hence, the present study aims to:
a) Explore whether patients with low-energy hip frac-
ture regain their pre-fracture levels in HRQOL and
GQOL compared with changes in age- and sex-matched
controls over a two year period;
b) Identify predictors of changes in HRQOL and
GQOL after two years.
Methods
Study design and study population
A case-control design with a prospective follow-up was
applied. The study was approved by the Regional Com-
mittee for Medical Research Ethics and the National
Data Inspectorate.
Patients with low-energy hip fractures aged 50 years
and older were recruited from an osteoporosis centre at
ar e g i o n a lh o s p i t a li ns o u t h e r nN o r w a yi n2 0 0 4a n d
2005. The hospital is the only referral centre for ortho-
paedic trauma in the region. Patients assessed at the
osteoporosis centre and willing to participate in a study
with assessment at the time of fracture and at one- and
two-year follow-up were included. Before inclusion, we
made sure that the fracture was not a result of high-
energy trauma and was caused only by minimal trauma
according to the definition of low-energy fracture [6].
We excluded patients with confusion or dementia, ser-
ious infection, patients not capable of giving informed
consent, patients not capable of speaking Norwegian,
and tourists. A nurse or doctor assessed the cognitive
function of the patients using a clinical judgment. Four
trained osteoporosis - nurses recruited the patients and
the controls, and administered the clinical assessments
and the questionnaires.
During the two-year inclusion period, 456 patients
with a low-energy hip fracture were treated at the hospi-
tal. Three hundred and seven of the patients were exam-
ined clinically at the osteoporosis centre, and 97 patients
were included in the study (Fig. 1). Of the patients with
hip fracture who were excluded from the examination at
the osteoporosis centre or from participating in the
study, most were excluded because of dementia or
because they were unable to give informed consent.
Two hundred and twenty-six age- and sex-matched
controls were randomly allocated from the national reg-
istry for the catchment area and invited by mail to parti-
cipate in the study at baseline. The controls were
identified consecutively along with patient recruitment.
If a potential control refused to participate or did not
respond to the invitation, a new control was invited.
Potential controls with a fracture the year before inclu-
sion, dementia or not capable of speaking Norwegian
were excluded. At two year follow-up we sex- and age-
matched (± five years) the 61 patients with a hip frac-
ture who were still in the study with 61 controls who
had valid measures at baseline and at one- and two-year
follow-up.
Data collection procedure
Patients were assessed at the osteoporosis centre and
included in the study a median of four days after the
fracture (interquartile range = two days). BMD measure-
ments were obtained and the patients were asked about
t h et i m eb e f o r et h ef r a c t u r eo c c u r r e dw i t hr e g a r dt o
demographic and clinical variables. Furthermore, exer-
cise, falls, and the use of health care resources the year
before the fracture were assessed. The controls were
asked these questions with reference to the period
immediately preceding inclusion. The patients were
asked to recall their HRQOL (Short Form 36) the four
weeks before fracture and GQOL (Quality of Life Scale)
at the time preceding the fracture, and the controls with
reference to the weeks and time preceding inclusion.
These data were used as baseline measures for both
groups. The same data collection performed at baseline
was repeated after one and two years.
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follow-up
Demographic and clinical variables
Demographic data, height and weight (to calculate BMI),
whether the patients and controls exercised for at least
30 minutes three times a week (walking or more inten-
sive exercise), self-reported co-morbidity, including
heart diseases, pulmonary diseases, neurological disor-
ders, urogenital disorders, gastrointestinal disorders,
endocrine disorders, inflammatory joint disorders, con-
nective tissue disorders, cancer, and mental disorders,
medication, smoking habits, and the number of self-
reported falls (without counting the fall related to the
fracture) the year before the fracture (inclusion in the
controls) were recorded. For co-morbidity, we also com-
puted a sum score of the number of diseases in each
patient, which was used in the multivariate analyses.
Bone density measurements
Standardized BMD measurements at lumbar spine L2-4
and femoral-neck and total hip on the non-fractured hip
(both hips in the controls) were performed by four
trained nurses using the same dual energy x-ray absorp-
tiometry (DXA) equipment (General Electric, Lunar
Prodigy) at baseline and at one- and two-year follow-up.
T h em a c h i n ew a ss t a b l eo v e rt h ee n t i r em e a s u r e m e n t
period. Long-term spine phantom in vitro coefficient of
variation (CV) for the whole period was 0.62%. The in
vivo CV for the measurement procedure was 1.19% at
456 patients with hip fractures in 2004/2005
(mean age = 81 ± 9 years, 71% females)
307 patients at the osteoporosis centre
(mean age = 80 ± 9 years, 72% females)
97 patients included in the study
(mean age = 75 ± 10 years, 73% females)
72 patients at one-year 
follow-up
61 hip patients at two-year
follow-up
137 excluded (mean age = 84 ± 8y e a r s ,  7 0 %  f e m a l e s )
12 unwilling (mean age = 82 ± 6y e a r s ,  7 5 %  f e m a l e s )
134 excluded (mean age = 84 ± 8y e a r s ,  6 8 %  f e m a l e s )
76 unwilling (mean age = 81 ± 8y e a r s ,  7 6 %  f e m a l e s )
5 died
20 dropped out
5 died
6 dropped out
Figure 1 Flow chart of the patients with hip fractures at baseline and at one- and two-year follow-up.
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Page 3 of 12lumbar spine L2-4, 0.95% at right total hip, and 0.89% at
left total hip. The BMD measurements were expressed
as T-scores (SD) with calculations based on the refer-
ence values in the DXA machine provided by the manu-
facturer. Osteoporosis was defined as T-score ≤ -2.5,
osteopenia as T-score > -2.5 and < -1.0, and normal
BMD as T-score ≥ -1.0, according to the WHO defini-
tion for osteoporosis [6].
HRQOL: Short Form-36 (SF-36)
The SF-36 was used to assess HRQOL [21,22]. The
questionnaire consists of 36 questions of self-reported
aspects of health. The SF-36 comprises eight domains:
physical functioning, physical role limitations, bodily
pain, general health, vitality, social functioning, emo-
tional role limitations and mental health, which also
were combined into physical and mental component
summary scales (PCS and MCS). Norwegian SF-36
norms were used to calculate the summary scales [23].
PCS and MCS indicate self-reported physical and mental
health, respectively. The SF-36 scales were scored
according to published scoring procedures, and each
scale was expressed using values from 0 to 100, with
100 representing excellent health [21,22]. At baseline
seven of the patients and 10 of the controls had one or
more missing responses. At one year follow-up 10 of
the patients and 15 of the controls had one or more
missing responses, and at two year follow-up 14 of the
patients and 12 of the controls had one or more missing
responses. Imputations for missing responses were car-
ried out in accordance with the guidelines given by the
developers of the questionnaire. Results from earlier stu-
dies indicate satisfactory reliability and validity of the
SF-36 [21,22,24,25]. For the entire study population,
Cronbach’s alphas in the study in the eight SF-36
domains at baseline were 0.91 for physical function, 0.86
for physical role limitation, 0.86 for bodily pain, 0.70 for
general health, 0.87 for vitality, 0.88 for social function,
0.75 for emotional role limitation and 0.78 for mental
health.
GQOL: Quality of Life Scale (QOLS)
The QOLS is a 16-item self-report instrument that mea-
sures GQOL [14,26,27]. In the questionnaire, GQOL is
understood as a broad range of human experiences
related to one’s overall well-being and satisfaction, and
comprises relationship and marital well-being, health
and functioning, and personal, social, and community
commitment [12,26,28]. The items are rated on seven-
point satisfaction scales. The questionnaire is scored by
adding up the items to obtain a total score from a mini-
mum of 16 to a maximum of 112. Higher scores indi-
cate better GQOL. At baseline 25 of the patients and 17
of the controls had one or more missing responses. At
one year follow-up 32 of the patients and 26 of the con-
trols had one or more missing responses, and at two
year follow-up 27 of the patients and 30 of the controls
had one or more missing responses. The items with
most missing responses were QOLS item number four
(having and rearing children) and item five (close rela-
tionship with spouse or other significant other). For
incomplete questionnaires, the missing values were
replaced with the mean value of the answered items of
the respondent when at least 80% of the items had a
valid response. Results from earlier studies show satis-
factory reliability and validity of the questionnaire
[27,29-31]. For the entire study population, Cronbach’s
alpha in the QOLS at baseline was 0.83.
Statistical analyses
Statistical analyses were carried out using the Statistical
Package for Social Sciences (SPSS) for Windows (version
16.0). Chi-square tests and independent t tests were
used to compare differences between groups. Paired
samples t tests were used to compare HRQOL and
GQOL between baseline and one-year follow-up, and
between baseline and two-year follow-up, in patients
and controls. General linear model (GLM) (repeated
MANOVA) were also applied to examine differences in
the repeated HRQOL and GQOL measures within the
groups. Furthermore, standard difference scores (s-
scores) were calculated by subtracting the mean SF-36
or QOLS scores at baseline from the mean scores of the
one- and two-year follow-ups, and then dividing by the
SD at baseline within the groups [32]. The s-scores
allow for comparisons across dependent variables and
were interpreted according to Cohen’s effect size index,
with 0.2 indicating a small difference, 0.5 a moderate
difference, and 0.8 or more a large difference [33,34].
Independent sample t tests were used to compare differ-
ences in HRQOL and GQOL between patients and con-
trols at baseline, one- and two-year follow-up.
Multiple linear regression analysis (procedure GLM in
the SPSS) was used to identify significant predictors of
changes in HRQOL (delta PCS and delta MCS) and
GQOL (delta QOLS) in the study-population (both
patients and controls). Delta scores (change scores) were
calculated by subtracting the baseline PCS, MCS and
QOLS scores from the two year PCS, MCS and QOLS
follow-up scores, respectively. Independent variables in
the multiple regression analyses were the demographic
variables of age (in five-year groups), sex, and marital
status (cohabiting/living alone), and the clinical variables
of BMD (normal BMD/. osteopenia/osteoporosis),
patients/controls, and co-morbidity (a sum score of the
number of diseases). These variables have been shown
to be covariates of HRQOL and/or GQOL in earlier stu-
dies [33]. The regression analyses were adjusted for total
PCS, MCS, or QOLS, respectively, at baseline. To
explore how much of the explained variance in HRQOL
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the patients/controls variable was excluded from the
multiple regression analyses while retaining the other
predictors in the equation. To test if the independent
variables in the regression models (potential effects pre-
dictors) of change in our dependent variables were sig-
nificantly different for patients and controls, interaction
terms involving the patient/control dichotomy and each
of the independent variables were entered one pair at a
time, while retaining the other independent variables
(main effects) in the model. The level of significance
was set at 0.05.
Results
Demographic and clinical characteristics
Baseline
Demographic and clinical characteristics at baseline of
those participants who completed the two-year follow-
up assessments are shown in Table 1. Compared with
the controls, the patients with hip fractures had signifi-
cantly lower weight (p < 0.001), lower BMI (p < 0.001),
were more likely to have osteoporosis (p < 0.001), live
alone (p = 0.045), be current smokers (p = 0.019), and
exercise less (p = 0.033). Two years after baseline, the
same differences between the groups were present, and,
in addition, the patients with hip fractures more often
used antiresorptive treatment (ART) than controls, 35
(57%) vs 11 (18%) (p < 0.001).
Only limited information was available with regard to
the patients excluded from examination at the osteo-
porosis centre (n = 137) or from participating in the
study (n = 134), and the patients unwilling to visit the
osteoporosis centre (n = 12) or unwilling to participate
in the study (n = 76) (Fig. 1). Of the patients excluded
from examination at the osteoporosis centre, 76 died
during the two-year period after the fracture, while of
the patients unwilling to visit the osteoporosis centre,
two patients died during the two-year period after the
fracture. Of the patients examined at the osteoporosis
centre but excluded from the study, 47 died during the
two-year period after the fracture, while of the patients
unwilling to participate in the study, 16 patients died
during the two-year period. Of the 456 patients with hip
fracture 33% died during a two-year period after the
fracture.
Dropouts
Of the 36 patients who dropped out during the two-year
follow-up period of the study, five died during the first
year of follow-up and another five died during the sec-
ond year of follow-up (Fig. 1). No controls died during
the study period. There were no significant differences
in age at baseline between the patients who attended
the two-year follow-up and the 10 patients who died or
the 26 patients who dropped out for other reasons.
Baseline scores of the 36 patients who dropped out
showed that more of these patients were living alone
(p = 0.031), and reported endocrine disorders (p = 0.023),
as well as lower scores within the HRQOL sub-dimensions
general health (p = 0.031) and vitality (p = 0.009).
Changes in HRQOL and GQOL
Baseline compared with one year after fracture
HRQOL decreased significantly between baseline and
one-year follow-up in the patients with hip fractures,
within all SF-36 domains (including PCS and MCS) (p <
0.04), except for social functioning (p = 0.091). The
decrease within the SF-36 domains persisted after using
GLM analyses (Fig. 2). The highest s-scores were
observed within physical functioning (s-score = -0.48),
and physical role limitations (s-score = -0.49) (Fig. 3).
There were no significant decreases in the SF-36 scores
in the controls (Fig. 2). Significantly decreased GQOL
scores (p < 0.001) were observed both in the patients
with hip fractures and in controls at one-year follow-up
(Fig. 2), with s-score = -0.57 and s-score = -0.59 respec-
tively (Fig. 3).
Baseline compared with two years after fracture
Compared with baseline, patients with hip fractures
reported significantly decreased HRQOL scores within
all SF-36 domains (including PCS and MCS) (p < 0.03),
except for social functioning (p = 0.073) and mental
health (p = 0.193). The decrease within the SF-36
domains persisted after using GLM analyses. Moderate
s-scores were observed within general health (s-score =
-0.59) and emotional role limitations (s-score = -0.55).
Physical functioning, and physical role limitations
showed s-score = -0.48 and s-score = -0.46, respectively.
There were no significant decreases in the controls (Fig.
3). Furthermore, significantly decreased GQOL scores
(p < 0.05) were observed both in the patients with hip
fractures and in controls at two-year follow-up (Fig. 2),
with s-scores = -0.35 and s-score = - 0.41, respectively
(Fig. 3).
Differences between patients with hip fractures and
controls
At baseline, i.e. prior to the fracture, the patients with
hip fractures reported significantly lower scores in the
HRQOL (SF-36) domains of physical functioning (p =
0.003), physical role limitation (p = 0.038), social func-
tioning (p = 0.009), and in GQOL (QOLS) (p = 0.013).
At one year follow-up, the patients reported lower
HRQOL in all of the eight domains and in GQOL (p <
0.01) compared to controls. The same pattern persisted
at two-year follow-up, except for the HRQOL domain
mental health (p = 0.08). The differences in the PCS
scores between patients (mean (SD)) 47 (11) and con-
trols 50 (8) (p = 0.094), and in the MCS scores, 49 (11)
vs 52 (8) respectively, (p =0 . 1 0 9 )a tb a s e l i n ew e r en o t
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significant differences between the patients in the PCS
scores 42 (11) and controls 51 (8), (p < 0.001), and in
the MCS scores 46 (12) and 52 (7), (p =0 . 0 0 2 ) .T h e
same pattern persisted at two-year follow-up showing a
PCS score in the patients of 42 (11) and in the controls
51 (8), (p < 0.001), and MCS scores of 46 (13) and 51
(8), (p = 0.037).
Predictors of change in HRQOL and GQOL at two-year
follow-up
Worsened physical health (SF-36-PCS) at two-year fol-
low-up was predicted by being a patient with hip frac-
ture (B = -5.8, p < 0.001) and old age (B = -1.0, p =
0.015). The variance in change uniquely attributable to
fracture was 0.267-0.156 = 0.111 (= 11%). Worsened
mental health (SF-36-MCS) was predicted by
Table 1 Demographics and clinical characteristics in patients with hip fractures (n = 61) and controls (n = 61) at
baseline
Patients with hip fractures Controls p*-value
Mean (SD) n (%) Mean (SD) n (%)
Demographics
Age (years) 73.7 (9.5) 72.6 (8.2) 0.502
(range 50-90 years)
Females 46 (75) 46 (75) 1.000
Current height (cm) 167.8 (8.7) 166.8 (7.9) 0.513
Current weight (kg) 66.4 (12.2) 74.7 (12.5) < 0.001
BMI (kg/m
2) 23.6 (3.7) 26.8 (3.7) < 0.001
Education 0.525
< 10 years 26 (46) 22 (37)
11-13 years 18 (32) 21 (35)
> 13 years 12 (21) 17 (28)
Cohabiting 26 (44) 38 (62) 0.045
Regular exercise** 36 (59) 47 (77) 0.033
Current smoker 16 (36) 6 (10) 0.019
Clinical characteristics
Current calcium and/or vitamin D treatment 12 (20) 18 (30) 0.207
Current ART 9 (15) 10 (16) 0.803
Current glucocorticoid treatment 9 (16) 3 (5) 0.083
Previous fractures 28 (46) 29 (48) 0.362
Mother fracture 18 (30) 18 (30) 0.930
≥ one fall in the previous year 27 (47) 19 (37) 0.289
Osteoporosis *** 35 (58) 12 (20) 0.001
Osteopenia 21 (34) 29 (48)
Normal BMD 5 (8) 19 (32)
Heart diseases 28 (48) 30 (49) 0.856
Pulmonary diseases 10 (16) 5 (8) 0.168
Neurological diseases 8 (13) 3 (5) 0.114
Endocrine disorders 5 (8) 4 (7) 0.729
Gastrointestinal disorders 6 (10) 11 (18) 0.191
Urogenital disorders 5 (8) 2 (3) 0.243
Inflammatory joint/connective tissue disorders 16 (26) 13 (21) 0.523
Cancer 8 (13) 6 (10) 0.570
Mental disorders 3 (5) 2 (3) 0.648
Co-morbidities
(range 0-6) ****
1.2 (1.1) 1.5 (0.9) 0.218
Continuous variables are presented as mean (SD) and group variables as numbers (%).
* Chi-square when comparing categorical data. Independent t tests with continuous variables. Bold p-values indicate significant differences between the groups.
** Exercise more than 30 minutes three times a week.
*** Osteoporosis at total hip and/or spine L2-L4.
**** Mean (SD) score of diseases including: heart diseases, pulmonary diseases, neurological disorders, urogenital disorders, gastrointestinal disorders, endocrine
disorders, inflammatory joint disorders and connective tissue disorders, cancer and mental disorders.
BMI, body mass index; ART, antiresorptive treatment (specific osteoporosis treatment comprising biphosphonates, or selective oestrogen-receptor modulators).
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Page 6 of 12co-morbidity (B = -2.2, p = 0.029), and the variance in
change uniquely attributable to fracture was 0.215-0.195 =
0.02 = 2%) (Table 2). Interaction terms between pairs of
each independent variable and patients/controls (tested
one pair at a time) revealed a significantly stronger effect
of old age on changes of physical health (PCS) among
patients with hip fracture than among controls. Further-
more, the negative effect of multiple co-morbidities at
baseline was particularly pronounced on changes of men-
tal health (MCS) among the patients.
Figure 2 HRQOL and GQOL mean scores (95% confidence intervals) at baseline, and at one- and two-year follow-up in patients with
hip fractures (n = 61) and controls (n = 61).
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change in GQOL, and no variance in change was
uniquely attributable to fracture (Table 2).
Discussion
Compared with pre-fracture the patients with hip frac-
tures reported modestly or moderately decreased
HRQOL and GQOL one year after fracture that
remained nearly unchanged at two-year follow-up,
whereas the controls reported no significant changes in
HRQOL and moderately or modestly decreased GQOL.
Changes in HRQOL physical health two years after
baseline were predicted by age and being a patient with
hip fracture, while co-morbidity predicted changes in
HRQOL mental health.
Our findings of lower pre-fracture scores of patients
compared with controls within some HRQOL domains
and decreased HRQOL one year after a low-energy hip
fracture, especially within the physical domains, are in
line with earlier studies in the field [8,9,17,18,35].
Furthermore, the patients seem to reach a plateau with
regard to HRQOL one year after the fracture. Our find-
ings show that the burden of a hip fracture on self-
reported physical health is particularly pronounced
among the oldest patients. These findings might empha-
size that health care providers should have a special
focus on the oldest patients with regard to targeted
rehabilitation efforts, so that the patients could achieve
the highest possible function and independence level in
everyday life.
The patients with hip fractures had lower GQOL
before the fracture occurred, compared with controls.
However, both the patients with a hip fracture and the
controls reported moderately decreased GQOL one year
after inclusion and modestly decreased GQOL two years
after inclusion. We might interpret these changes as
being to aging. The findings are in line with changes
over a period of one or two years in other patient
groups [36,37]. In contrast to our results, studies have
s h o w nt h a tG Q O Ld o e sn o ts e e mt ob ei n f l u e n c e db y
old age [38,39]. Furthermore, it is possible that those
patients and controls who agreed to participate in our
study did so at a point in time when their GQOL was
better than their own typical (long-term) level, thus
creating a “regression to mean” effect two years later
when these same individuals may have returned to their
usual level of GQOL [33]. There seems to be a differ-
ence regarding how a low-energy hip fracture influences
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Figure 3 Standard difference scores (s-scores) of HRQOL and GQOL at one- and two-year follow-up, compared with baseline for
patients with hip fracture (n = 61) and controls (n = 61) with valid HRQOL and GQOL change-scores.
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patients’ experiences of change in overall satisfaction
with life (i.e., GQOL) appear to be in line with that of
the elderly population in general. In contrast, the
patients’ experience of their health (i.e., HRQOL) is sub-
stantially influenced by the fracture.
To be a patient with a hip fracture was a strong pre-
dictor of worsened physical health in an elderly popula-
tion, even when known correlates of decreased physical
health such as co-morbidity, age, and marital status
[40-42] were adjusted for. This indicates a strong asso-
ciation between a hip fracture and worsened health. In
contrast to previous studies, we did not find BMD as a
significant predictor of changes in HRQOL, and there is
no clear explanation for this [8,16-18,35,43]. The find-
ings underline the burdens and complexity related to a
hip fracture.
The overview of the excluded patients and the patients
unwilling to participate in this study shows that those
who were included were probably the healthiest and the
youngest ones. The majority of the excluded patients
were excluded because of dementia or because they
were unable to give informed consent. Furthermore,
nursing home patients who were sent home within two
days after fracture were not included in the study. These
patients suffered from mental and physical diseases, and
were less able to take care of activities of daily living
than the patients included in the study. However, even
in the relatively exclusive group of patients included in
the study, the baseline HRQOL level was not regained
over the two-year period. Furthermore, the relatively
high number of excluded patients indicates that many
patients with hip fractures are not capable of self-report-
ing their HRQOL and GQOL. This may be the reason
why patient-based outcomes such as HRQOL and
GQOL among patients with hip fractures are available
only for rather limited samples. Thus, the knowledge
derived from this study, as well as others, can probably
be generalized primarily to a rather healthy sub-group
of the elderly population with hip fractures. We do not
know the reason for the 10 deaths among the patients
during the two-year follow-up. However, we could
assume that the deaths might be related to age, co-mor-
bidity or complications associated with the hip fracture.
The patients’ ability to correctly recall their HRQOL
and GQOL before the hip fracture may be questioned.
One possible way is to apply epidemiological surveys of
QOL and from a huge cohort identify people who
Table 2 Predictors of change in HRQOL (delta PCS and delta MCS) and GQOL (delta QOLS) in patients with hip
fractures (n = 61) and controls (n = 61)
PCS MCS QOLS
Adj B 95% CI p Adj B 95% CI p Adj B 95% CI p
Demographic
Age* -1.0 (-1.9, -0.2) 0.015 0.05 (-1.1, 1.2) 0.926 -0.4 (-1.7, 0.9) 0.529
Male -0.5 (-3.8, 2.9) 0.783 -2.4 (-7.0, 2.2) 0.310 -1.4 (-6.5, 3.7) 0.590
Female Ref Ref Ref
Living alone -2.9 (-5.8, 0.0) 0.050 3.5 (-0.6, 7.5) 0.093 -0.1 (-4.6, 4.4) 0.968
Cohabiting Ref Ref Ref
Clinical
Hip patients -5.8 (-8.7, -2.8) < 0.001 -3.8 (-7.9, 0.3) 0.071 -1.7 (-6.1, 2.7) 0.447
Controls Ref Ref Ref
Osteopenia** -0.8 (-4.3, 2.8) 0.671 -0.5 (-5.5, 4.5) 0.837 -3.2 (-8.8, 2.4) 0.265
Osteoporosis** 0.2 (-3.9, 4.3) 0.918 -2.1 (-7.9, 3.6) 0.461 1.4 (-4.7, 7.6) 0.649
Normal BMD Ref Ref Ref
Co-morbidity 0.0 (-1.4, 1.4) 0.999 -2.2 (-4.1, -0.2) 0.029 -0.3 (-2.6, 2.0) 0.783
QOL
PCS incl. -0.3 (-0.5, -0.2) < 0.001
MCS incl. -0.5 (-0.8, -0.3) < 0.001
QOLS incl. -0.2 (-0.5, 0.0) 0.049
R2 adj 26.7% 21.5% 2.3%
Adjusted unstandardized regression coefficients, 95% CI, and p values.
p-values marked with bold indicate statistically significance. The demographic and clinical variables in column one are used in all three
models, in addition PCS at inclusion is used in model one, MCS at inclusion in model two and QOLS at inclusion in model three
* Age in five-year groups.
** Osteopenia/osteoporosis at total hip and/or spine L2-L4.
BMD, bone mineral density; PCS, SF-36 physical component summary scale; MCS, SF-36 mental component summary scale
(range 0-100, where 100 = high HRQOL); QOLS, Quality of Life Scale (16-112, where 112 = high GQOL).
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pared with those not fracturing. To perform such a
large study was not possible for us to do. And a cohort
study would also have limitations because QOL may
change between the time of data capture and fracture,
and thus may no longer be valid for the time of fracture.
Thus, an alternative method is to use pre-injury recall,
like in this trauma study and in other studies [9,18,35].
Changes in health status, such as that resulting from
experiencing a fracture, might cause a shift in how the
patients judged their HRQOL and GQOL (selective
reporting bias and response shift) [44]. On the other
hand, patients who have experienced a recent change in
health are more likely to make accurate health-related
responses [32,45,46]. To minimize the recall problem it
is recommended that QOL assessments should be per-
formed with the shortest possible time lag after the frac-
ture event, which we aimed for in our study. The
elapsed time from fracture to assessment was relatively
short and most patients completed the baseline QOL
questionnaires within five days after fracture. Thus, it
seems unlikely that the patients would have forgotten
about their QOL before and at the time of the fracture.
To minimize further the retrospective design of our
baseline data, the questionnaires were administered with
an instruction that the patients should think of the per-
iod before the fracture. Furthermore, demographic and
clinical characteristics before the fracture were also
based on recall, and the validity on reports of numbers
of e.g. fall may be questioned. Two studies [47,48] have
shown that the number of falls reported by recall, may
be underestimated among elderly. However, as the parti-
cipants are the only source of information in these mat-
ters, we are forced to rely on self-reports.
This study has a case-control, prospective, and longi-
tudinal design, and population based controls were cho-
sen as the control population. We could argue that a
hospital based control population would have been bet-
ter to assess the influence of fracture as well as the out-
come. On the other hand, the disease giving rise to the
hospitalization and the impact of the disease, would
have influenced characteristics and outcomes in ways
which would be hard to assess. Furthermore, compari-
sons with elderly from the general population were a
guiding principle in this study. Other studies have
recruited controls from general practitioners [8,18], both
cases and controls were recruited from general practi-
tioners [17,43,49], or population-based HRQOL (SF-36)
norms were used in cross-sectional comparisons
[7,16,35].
A low-energy hip fracture seems to have substantial
clinical implications with respect to HRQOL in most
patients. Elderly people who barely manage alone before
the fracture might be in need of assistance afterwards.
This assistance might include both practical help and
community care. An intensive interdisciplinary approach
is therefore required to improve functioning in everyday
life, which would also include a focus on patient-
reported outcomes such as HRQOL and GQOL.
Furthermore, the impact of a hip fracture on self-
reported outcomes, such as the HRQOL revealed in our
study, might give support to the implementation of
patient-reported outcomes in daily clinical practice, and
thereby reach the patient’s perspective and evaluation of
the health care both in the hospitals and the rehabilita-
tion units in the municipalities [19,20]. With a growing
number of elderly and an incidence of hip fractures in
Norway that is among the highest in the world [2-4],
low-energy fractures seem to be a challenge for both the
society and the individuals in the years to come. An
increased contact and collaboration between the differ-
ent levels of care might thereby be required, i.e. between
hospitals and community health care [19,20].
Conclusion
The patients with hip fractures reported significantly
decreased HRQOL and GQOL one year after the frac-
ture. Furthermore, minor changes in HRQOL and
GQOL between one- and two-year follow-up were seen,
and the patients did not regain their HRQOL and
GQOL. However, the controls also reported decreased
GQOL at one- and two-years follow-up. Moreover, a
hip fracture is a strong predictor of worsened physical
health. The findings of this study may be used to high-
light the importance of disease and trauma prevention,
early and targeted rehabilitation efforts to increase func-
tion and thereby coping after the fracture, and effective
contact and collaboration between the hospital and the
care unit in the municipality to reach these goals.
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